ArticleEMBO molecular medicine2020
Novel tau biomarkers phosphorylated at T181, T217 or T231 rise in the initial stages of the preclinical Alzheimer's continuum when only subtle changes in Aβ pathology are detected.
Marc Suárez-Calvet et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
249 papers cite itlatest 60 shown
this paperpooled ittrialcites it